Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 347601 - 347620 out of 485363 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Poland | (R03AK08) formoterol and beclometasone | Formodual, aerozol inhalacyjny, roztwór, 200+6 µg/dawkę | 1 poj.po 180 daw., (200 mcg + 6 mcg)/dawkę , 1 poj. 180 dawek | Retail price with vat |
$0-0 |
$0-0 |
n/a | ChiesiFarmaceuticiS.p.A. |
| Poland | (R03AK08) formoterol and beclometasone | Fostex, aerozol inhalacyjny, roztwór, 200+6 µg/dawkę | 1 poj.po 180 daw., (200 mcg + 6 mcg)/dawkę inh. , 1 poj. 180 dawek | Retail price with vat |
$0-0 |
$0-0 |
n/a | ChiesiFarmaceuticiS.p.A. |
| Poland | (R03AK14) indacaterol and mometasone | Atectura Breezhaler, proszek do inhalacji w kaps. tw., 125+127,5 µg | 30 szt., 125 mcg + 127,5 mcg , 1 inhalator | Retail price with vat |
$0-0 |
$0-0 |
Asthma | NovartisEuropharmLimited |
| Poland | (R03AK14) indacaterol and mometasone | Atectura Breezhaler, proszek do inhalacji w kaps. tw., 125+260 µg | 30 szt., 125 mcg + 260 mcg , 1 inhalator | Retail price with vat |
$0-0 |
$0-0 |
Asthma | NovartisEuropharmLimited |
| Poland | (R03AK14) indacaterol and mometasone | Atectura Breezhaler, proszek do inhalacji w kaps. tw., 125+62,5 µg | 30 szt., 125 mcg + 62,5 mcg , 1 inhalator | Retail price with vat |
$0-0 |
$0-0 |
Asthma | NovartisEuropharmLimited |
| Poland | (R03AL01) fenoterol and ipratropium bromide | Berodual, roztwór do nebulizacji, 0,5+0,25 mg/ml | 20 ml, (0,5 mg + 0,25 mg)/ml , 1 butelka 20 ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimInternationalGmbH |
| Poland | (R03AL03) vilanterol and umeclidinium bromide | Anoro Ellipta, proszek do inhalacji, podzielony, 55+22 µg | 1 inhalator po 30 dawek, 55 mcg + 22 mcg , 1 inhalator 30 dawek | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | GlaxoSmithKline(Ireland)Limited |
| Poland | (R03AL04) indacaterol and glycopyrronium bromide | Ultibro Breezhaler, proszek do inhalacji w kaps. twardej, 85+43 µg | 30 szt. + inhal., 85 mcg + 43 mcg , 1 inhalator | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | NovartisEuropharmLimited |
| Poland | (R03AL06) olodaterol and tiotropium bromide | Spiolto Respimat, roztwór do inhalacji, 2,5+2,5 µg | 1 wkład 30 dawek + 1 inh., 2,5 mcg + 2,5 mcg , 1 inhalator Respimat | Retail price with vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimInternationalGmbH |
| Poland | (R03AL06) olodaterol and tiotropium bromide | Spiolto Respimat, roztwór do inhalacji, 2,5+2,5 µg | wkład uzupełniający 30 dawek, 2,5 mcg + 2,5 mcg , 1 wkład 5 mcg (2,5 mcg + 2,5 mcg) uzupełniający | Retail price with vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimInternationalGmbH |
| Poland | (R03AL08) vilanterol, umeclidinium bromide and fluticasone furoate | Trelegy Ellipta, proszek do inhalacji, podzielony, 92+55+22 µg/dawkę inhalacyjną | 1 inhalator 30 dawek, (92 mcg + 55 mcg + 22 mcg)/dawkę inh. , 1 inhalator 30 dawek | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | GlaxoSmithKlineTradingServicesLimited |
| Poland | (R03AL09) formoterol, glycopyrronium bromide and beclometasone | Trimbow, aerozol inh., roztwór, 87+5+9 µg/dawkę inhalacyjną | 1 poj. a 180 daw., 87 mcg + 5 mcg + 9 mcg , 1 poj. 180 dawek | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | ChiesiFarmaceuticiS.p.A. |
| Poland | (R03AL11) formoterol, glycopyrronium bromide and budesonide | Trixeo Aerosphere, aerozol inh., zawiesina, 5+7,2+160 µg | 1 poj. a 120 daw., 5 mcg + 7,2 mcg + 160 mcg , 1 poj. 120 dawek | Retail price with vat |
$0-0 |
$0-0 |
Pulmonary Disease, Chronic Obstructive | AstraZenecaAB |
| Poland | (R03AL12) indacaterol, glycopyrronium bromide and mometasone | Enerzair Breezhaler, proszek do inhalacji w kaps. tw., 114+46+136 µg | 30 szt., 114 mcg + 46 mcg + 136 mcg , 1 inhalator | Retail price with vat |
$0-0 |
$0-0 |
Asthma | NovartisEuropharmLimited |
| Poland | (R03BA02) budesonide | BDS N, zawiesina do nebulizacji, 0.25 mg/ml | 20 amp.po 2 ml, 0,25 mg/ml , 20 amp. 2 ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | AurovitasPharmaPolskaSp.zo.o. |
| Poland | (R03BA02) budesonide | BDS N, zawiesina do nebulizacji, 0.5 mg/ml | 20 amp.po 2 ml, 0,5 mg/ml , 20 amp. 2 ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | AurovitasPharmaPolskaSp.zo.o. |
| Poland | (R03BA02) budesonide | Benodil, zawiesina do nebulizacji, 0.125 mg/ml | 20 amp.po 2 ml, 0,125 mg/ml , 20 amp. 2 ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | ZakładyFarmaceutycznePOLPHARMAS.A. |
| Poland | (R03BA02) budesonide | Benodil, zawiesina do nebulizacji, 0.25 mg/ml | 20 amp.po 2 ml, 0,25 mg/ml , 20 amp. 2 ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | ZakładyFarmaceutycznePOLPHARMAS.A. |
| Poland | (R03BA02) budesonide | Benodil, zawiesina do nebulizacji, 0.5 mg/ml | 20 amp.po 2 ml, 0,5 mg/ml , 20 amp. 2 ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | ZakładyFarmaceutycznePOLPHARMAS.A. |
| Poland | (R03BA02) budesonide | Budesonide Easyhaler, proszek do inhalacji, 100 µg/dawkę | 1 inh.po 200 daw., 100 mcg/dawkę , 1 inhalator 200 dawek, zestaw startowy | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrionCorporation |
Pages
